AFP WORDLINK

Need a brochure to explain myasthenia gravis to your patients? Perhaps you are developing a training program for pharmaceutical sales representatives promoting a new treatment for schizophrenia. Or you may be putting together a report on nephrotoxicity based on a two-day meeting among specialists that is intended for a mixed audience of government agents, physicians, and the general public.

Primary location: Canada